FLSM
MORF

Frazier Life Sciences Management’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Frazier Life Sciences Management’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-265,511
Closed -$15.2M – 54
2023
Q2 		$15.2M Buy
265,511
+51,271
+24% +$2.68M 0.91% 29
2023
Q1 		$8.06M Buy
+214,240
New +$7.89M 0.58% 33

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Frazier Life Sciences Management's MORF Position: Q3 2023 in Review

Frazier Life Sciences Management sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2023, closing a stake of 265,511 shares — an estimated $15.2M sold.

Frazier Life Sciences Management first reported a position in MORF in Q1 2023 and held it in 2 quarters. The position peaked at $15.2M in Q2 2023. 134 funds tracked by Wall St. Rank hold MORF as of Q3 2023.

  • Frazier Life Sciences Management reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Frazier Life Sciences Management sold 265,511 Morphic Holding, Inc. Common Stock shares in Q3 2023, an estimated $15.2M.
  • Frazier Life Sciences Management first reported a position in Morphic Holding, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Frazier Life Sciences Management's Morphic Holding, Inc. Common Stock position peaked at $15.2M in Q2 2023.
  • 134 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2023.

Based on Frazier Life Sciences Management's 13F filing for Q3 2023, filed 14 Nov 2023.